Interventional

Non-PV Triggers Responsible for AF Maintenance After Multiple Failed PV Isolation

Non-PV Triggers Responsible for AF Maintenance After Multiple Failed PV Isolation

Ablating non-PV triggers is associated with improved outcomes in patients with atrial fibrillation with 2 or more failed PVI procedures.

Vitamin D as a Means of Cardioprotection in Elective PCI

Vitamin D as a Means of Cardioprotection in Elective PCI

Vitamin D did not produce a substantial preventive effect on cardiac injury during percutaneous coronary intervention.

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

By

Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

Is Echocardiography Missing Mild CTEPH Cases That May Benefit From Endarterectomy?

By

Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.

Bleeding Risk Reduced in Atrial Fibrillation After PCI With Dual Therapy

Bleeding Risk Reduced in Atrial Fibrillation After PCI With Dual Therapy

For patients with atrial fibrillation who undergo percutaneous coronary intervention, the risk of bleeding is lower with dual therapy vs triple therapy.

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

By

In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

Which Revascularization Strategy Produces Better Outcomes in Type 1 Diabetes?

By

Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.

Lower Event Free Survival With Off-Pump vs On-Pump CABG

Lower Event Free Survival With Off-Pump vs On-Pump CABG

Coronary-artery bypass grafting patients were found to live longer if their surgeons performed the operation with cardiopulmonary bypass.

After Cardiac Surgery, Patients With Obesity Require More ICU Resources

After Cardiac Surgery, Patients With Obesity Require More ICU Resources

For patients undergoing cardiac surgery, increasing obesity is associated with increased intensive care unit resource utilization.

Valve Type May Predict Myocardial Injury After Transfemoral TAVR

Valve Type May Predict Myocardial Injury After Transfemoral TAVR

Myocardial injury occurs frequently following transfemoral transcatheter aortic valve replacement.

Avalus Surgical Aortic Valve Receives FDA and European Commission Approval

Avalus Surgical Aortic Valve Receives FDA and European Commission Approval

By

A new pericardial aortic surgical valve has received US Food and Drug Administration and European Commission approval.

CCTA Shows Diagnostic Accuracy Post-Vascular Scaffold Implantation

CCTA Shows Diagnostic Accuracy Post-Vascular Scaffold Implantation

Coronary computed tomography angiography is an accurate method of assessing angiographic outcomes after bioresorbable vascular scaffold implantation.

 FDA Issues Safety Alert for Revascularization Device Used in Acute Ischemic Stroke

FDA Issues Safety Alert for Revascularization Device Used in Acute Ischemic Stroke

By

The delivery wire component of the Penumbra 3D revascularization device may break or separate during use.

Anticoagulant Effect of Dabigatran Successfully Reversed in Emergency Situations

Anticoagulant Effect of Dabigatran Successfully Reversed in Emergency Situations

Idarucizumab can effectively reverse the anticoagulant effect of dabigatran.

FDA Approves New Pericardial Aortic Valve

FDA Approves New Pericardial Aortic Valve

By

The FDA approved a new pericardial aortic valve for replacement of native or prosthetic valves.

Frailty Scale Predicts Death and Disability After Aortic Valve Replacement

Frailty Scale Predicts Death and Disability After Aortic Valve Replacement

By

The Essential Frailty Toolset is a fast and effective predictor of death and worsening disability following valve replacement.

Heart Stents Coated With Sildenafil May Reduce Clots, Aortic Stenosis

Heart Stents Coated With Sildenafil May Reduce Clots, Aortic Stenosis

Sildenafil-coated stents may help reduce clots.

Off-Label TAVR Demonstrates Similar Mortality as On-Label

Off-Label TAVR Demonstrates Similar Mortality as On-Label

One-year mortality is similar for individuals undergoing transcatheter aortic valve replacement (TAVR) for on-label or off-label indications

Embolic Protection Device Useful Post Carotid Artery Stenting

Embolic Protection Device Useful Post Carotid Artery Stenting

An embolic protection device has been proven to reduce risk for in-hospital stroke, major stroke or death and stroke after carotid artery stenting.

Anticoagulant Recall:  Incorrect Dose Discovered in Bottle

Anticoagulant Recall: Incorrect Dose Discovered in Bottle

By

Bristol-Myers Squibb is recalling one lot of Eliquis after finding that 1 of the bottles contained the wrong dosage.

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

By

The American Association for Thoracic Surgery has developed evidence-based guidelines on the use of surgical ablation for atrial fibrillation.

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

By

The response to endovascular treatment for acute ischemic stroke after 2 years was as good as in the first 90 days.

Ischemic Outcomes in Acute Coronary Syndrome Not Affected by Gender

Ischemic Outcomes in Acute Coronary Syndrome Not Affected by Gender

Gender has no effect on the outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention receiving clopidogrel, prasugrel, or ticagrelor.

Postoperative Atrial Fibrillation Predicted by Plasma Catecholamines

Postoperative Atrial Fibrillation Predicted by Plasma Catecholamines

The composite preoperative adrenergic plasma marker was associated with a 4-fold increase of developing postoperative atrial fibrillation.

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

By

Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

By

The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.

Theraputic Stem Cell-Sheet Transplantation May Improve Cardiomyopathy Symptoms

Theraputic Stem Cell-Sheet Transplantation May Improve Cardiomyopathy Symptoms

A small phase I study identified positive benefits from utilizing stem cell-sheet transplantation as a therapy for ischemic and dilated cardiomyopathy.

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

By

Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

By

Revised coronary revascularization criteria rated whether coronary interventions are appropriate in tables organized according to practice patterns.

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

By

Target lesion failure was 5.8% at 1 year after implantation with the SYNERGY stent.

Sign Up for Free e-Newsletters